Immunome, Inc. - Common Stock — Cash Flow (NASDAQ:IMNM) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -12.13 M-18.23 M-28.69 M-7.57 M-110.79 M-190.92 M -196.5 M Cash from investing activities -586 K-79 K-248 K-30.48 M-85.06 M60.8 M 43.7 M Cash from financing activities 49.94 M27.77 M32 K116.41 M240.53 M640.36 M 477.99 M Free cash flow -12.13 M-18.23 M-28.69 M-7.57 M-110.79 M-200.6 M -205.52 M

News

Techne (TECH) Misses Q3 Earnings and Revenue Estimates

Exelixis (EXEL) Tops Q1 Earnings Estimates

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Lags Revenue Estimates

Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?

Bienaime buys Immunome (IMNM) shares worth $43,670

Immunome: Upcoming NDA, Valuation, And Investment Case (NASDAQ:IMNM)

Immunome stock hits 52-week high at $26.74

Immunome stock reaches 52-week high at $25.32

Immunome (IMNM) CEO Siegall buys $100k in shares

Guggenheim reiterates Buy rating on Immunome stock following $400M financing

Tsai Philip buys $204,899 in Immunome stock

Immunome: Maintaining "Strong Buy" On Successful RINGSIDE Trial With Varegacestat (IMNM)